TL;DR
Noom has announced a new program offering access to prescription GLP-1 medications alongside its behavioral support services. The initiative aims to enhance weight loss outcomes by integrating medication with psychological guidance. Details about eligibility, medication options, and support tools are now available, with further developments expected.
Noom has officially launched its GLP-1Rx program, offering users access to prescription GLP-1 medications such as Ozempic and Zepbound, starting at $99 if clinically appropriate. The program combines medication with Noom’s established behavioral support, aiming to improve weight loss outcomes and long-term health management.
The program is developed by medical professionals and integrates licensed clinician oversight with Noom’s psychological and behavioral change approach. Eligible participants can take a quiz, connect with a qualified clinician, and, if approved, begin a personalized treatment plan that includes medication management and ongoing support.
Participants also gain access to the GLP-1 Companion, a digital tool designed to assist with treatment navigation, side effect management, nutrition, and movement guidance. This support system has shown to increase weight loss success, with engaged users losing approximately 25% more weight than less engaged members, according to Noom.
Medications offered include brand-name drugs like Ozempic and Zepbound, with prices starting at $69 plus out-of-pocket costs for the medication, depending on insurance. The program emphasizes a holistic approach, combining medication with psychological support, community engagement, and personalized coaching to promote sustainable health habits.
Implications of Noom’s Integrated Weight Loss Approach
This development is significant because it represents a shift toward combining pharmacological treatments with behavioral health strategies within a digital platform. By offering prescription GLP-1 medications alongside psychological support, Noom aims to improve the effectiveness and sustainability of weight loss efforts. The program’s affordability and accessibility could influence how other digital health companies approach obesity management, potentially expanding access to medically supervised weight loss treatments outside traditional clinical settings. However, the long-term impacts and clinical outcomes of this integrated approach remain to be fully evaluated.
OZEMPIC 9 MG TAB
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background on Noom’s Behavioral and Medical Support Integration
Noom has built its reputation on a psychology-based approach to weight management, emphasizing behavior change, community support, and ongoing coaching. The company has previously focused on lifestyle modifications without direct access to medications. The recent introduction of the GLP-1Rx program marks a notable expansion, aligning with broader trends in obesity treatment that increasingly incorporate pharmacotherapy, such as Noom’s approach to weight management, which have shown promising results in clinical trials.
This move follows growing demand for accessible, integrated weight loss solutions amid rising obesity rates and the popularity of medications like Ozempic. While some healthcare providers remain cautious about widespread use, the FDA has approved several GLP-1 drugs for weight management, fueling interest among consumers and digital health platforms alike.
It is not yet clear how Noom’s program will be received by the medical community or how it will be regulated, but the company emphasizes that all prescriptions are issued by licensed clinicians following medical guidelines.
“Our goal is to provide a comprehensive, accessible solution that combines proven medication with behavioral support to help users achieve lasting health changes.”
— a Noom spokesperson
GLP-1 Activator Probiotic Supplement for Weight Loss, Gut Health, Energy & Metabolic Support – Akkermansia, Berberine, Gymnema, Resveratrol, EGCG & Hops – Appetite Control for Women & Men – 90Capsules
Made In USA
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Unanswered Questions About Program Implementation
It remains unclear how many users will qualify for the program, what the exact criteria are, and how the program will be scaled nationally. The long-term effectiveness and safety of combining Noom’s psychological support with prescription GLP-1 medications are still being evaluated, and regulatory considerations are ongoing.
Additionally, the impact on traditional healthcare providers and insurance coverage for prescriptions through Noom has not been fully clarified. The program’s reception by the broader medical community and its adherence to clinical guidelines are also areas to watch.
Noom GLP-1Rx program support tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps for Noom’s GLP-1Rx Program Rollout
Noom is expected to release additional details about user eligibility, clinical oversight processes, and program expansion in the coming months. Monitoring user outcomes, safety data, and patient feedback will be critical to assessing the program’s success.
Further integration with healthcare providers and potential partnerships with insurers could shape the program’s future accessibility. Regulatory reviews and clinical studies may also influence how the program evolves and is perceived within the healthcare system.
Greater Goods Smart Scale – Track Your Weight Loss Journey with Verified Accuracy & Smart Goal-Based Monitoring | Wi-Fi & Bluetooth Sync
Track Every Milestone: This smart scale syncs with our Weight Gurus app to turn every weigh-in into charts,…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Who is eligible for Noom’s GLP-1Rx program?
Eligibility is determined through a quiz and consultation with a licensed clinician, who assesses medical suitability based on individual health profiles.
What medications are offered through the program?
Medications include brand-name drugs like Ozempic and Zepbound, with prices starting at $69 plus out-of-pocket costs, depending on insurance coverage.
Is this program available nationwide?
Details about geographic availability are still being finalized, but initial launches are expected to focus on select markets with plans for broader rollout.
How does Noom support medication management?
Participants have ongoing access to clinicians, the GLP-1 Companion app for guidance, and community support to help manage side effects and maintain progress.
What are the potential risks of combining medication with behavioral support?
While combining these approaches can enhance outcomes, long-term safety data is still emerging, and medical oversight is essential to mitigate risks.
Source: Greatist
